Market Reports /
by -
9 years ago
22 Apr 2015 - Aus shares wobble lower ahead of CPI. PanAust Limited (ASX:PNA) delivers strong March quarter after cutting costs and rejecting a $1.1 billion takeover offer.
Market Reports /
by -
9 years ago
09 Apr 2015 - Miners push ASX 0.5% lower. Singapore Telecommunications Limited’s (ASX:SGT) Australian arm Optus renews a managed network services contract with the ATO.
Market Reports /
by -
9 years ago
09 Apr 2015 - ASX wobbles lower on resource stocks. Novogen Limited (ASX:NRT) shows experimental drug Anisina is highly effective against melanoma.
Market Reports /
by -
9 years ago
02 Apr 2015 - Aus shares shake off weak leads. QBE Insurance Group Limited (ASX:QBE) flag increased dividends after a return to profitability.
Market Reports /
by -
9 years ago
30 Mar 2015 - PanAust Limited (ASX:PNA) jumps 40 per cent after scoring another takeover offer from one of its shareholders.
Company News /
by -
9 years ago
30 Mar 2015 - Novogen Limted (ASX:NRT) says that it has key data proving its experimental anti-cancer drug Cantrixil is highly effective at killing ovarian cancer cells.
Company News /
by -
9 years ago
19 Mar 2015 - Novogen Limited (ASX:NRT, NASDAQ:NVGN) confirms the potential of one of its drugs to become a major new chemotherapy.
Company News /
by -
9 years ago
05 Mar 2015 - Novogen Limited (ASX:NRT, NASDAQ:NVGN) soars after revealing promising study results.
Market Reports /
by -
9 years ago
17 Dec 2014 - Aus shares make slight gains. Shares in Novogen Limited (ASX:NRT, NASDAQ:NVGN) took a wild ride after jumping almost 100 per cent yesterday.
Company News /
by -
9 years ago
17 Dec 2014 - Novogen Limited (ASX:NRT, NASDAQ:NVGN) soars after the drug developer announces a medical breakthrough.
Company News /
by -
10 years ago
05 Mar 2014 - Cancer drug company Novogen Limited (ASX:NRT) has announced two new directors and a strategic advisor.
Market Reports /
by -
14 years ago
The Australian share market is likely to open higher today. Novogen Ltd (ASX:NRT) says trials of an ovarian cancer drug have been unsuccessful.